CIRAX | TEMQX | CIRAX / TEMQX | |
Total Expense Ratio | 0.62 | 1.76 | 35% |
Annual Report Gross Expense Ratio | 0.62 | 1.76 | 35% |
Fund Existence | 24 years | 45 years | - |
Gain YTD | 15.337 | 11.655 | 132% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 118B | 2.69B | 4,390% |
Annual Yield % from dividends | 2.90 | 3.62 | 80% |
Returns for 1 year | 11.89 | 10.63 | 112% |
Returns for 3 years | 40.44 | 33.59 | 120% |
Returns for 5 years | 55.33 | 44.64 | 124% |
Returns for 10 years | 94.63 | 29.39 | 322% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 37.99 | 0.91 | +2.44% |
Global X Genomics & Biotechnology ETF | |||
MQY | 11.19 | 0.15 | +1.36% |
Blackrock Muni Yield Quality Fund | |||
AVSD | 70.10 | 0.41 | +0.59% |
Avantis Responsible International Eq ETF | |||
VYM | 139.55 | 0.26 | +0.19% |
Vanguard High Dividend Yield ETF | |||
LGCF | 33.00 | N/A | N/A |
Themes US Cash Flow Champions ETF |